Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

CRH Medical Corporation Cmn (CRHM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 457,258
  • Shares Outstanding, K 73,990
  • Annual Sales, $ 78,350 K
  • Annual Income, $ 10,560 K
  • 36-Month Beta -0.23
  • Price/Sales 5.62
  • Price/Cash Flow 16.98
  • Price/Book 4.26

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.95 +24.85%
on 05/18/17
6.85 -9.78%
on 04/27/17
-0.42 (-6.36%)
since 04/26/17
3-Month
4.95 +24.85%
on 05/18/17
9.25 -33.19%
on 04/11/17
-0.92 (-12.96%)
since 02/24/17
52-Week
3.12 +98.08%
on 05/27/16
9.25 -33.19%
on 04/11/17
+3.09 (+100.00%)
since 05/26/16

Most Recent Stories

More News
The Growth of the Global Pharmaceuticals Market

A research report by DCAT Connect claims that the total global spend for pharmaceuticals through 2021 will increase by $367 billion on a constant-dollar basis, according to QuintilesIMS. Spending is measured...

AUPH : 6.36 (-3.49%)
THERF : 5.1640 (+3.49%)
CXRX : 1.29 (unch)
QPT.VN : 0.150 (+3.45%)
CRHM : 6.18 (+3.87%)
QPTFF : 0.1200 (unch)
CRH Medical Corporation Increases Total Revenue and Total Operating EBITDA by 63% During the First Quarter of 2017

CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), today announced its financial results for the quarter ended March 31, 2017.

CRH.TO : 8.34 (+3.60%)
CRHM : 6.18 (+3.87%)
CRH Medical Corporation To Present at the Bloom Burton & Co. Healthcare Investor Conference

CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate in the Bloom Burton & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in Toronto, Ontario....

CRH.TO : 8.34 (+3.60%)
CRHM : 6.18 (+3.87%)
CRH Medical Corporation To Present at the Bloom Burton & Co. Healthcare Investor Conference

CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate in the Bloom Burton & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in Toronto, Ontario....

CRH.TO : 8.34 (+3.60%)
CRHM : 6.18 (+3.87%)
CRH Medical Corporation To Announce Unaudited Q1 2017 First Quarter Results on April 26, 2017

CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its unaudited results for the quarter ended March 31, 2017, on Wednesday, April 26, after market close.

CRH.TO : 8.34 (+3.60%)
CRHM : 6.18 (+3.87%)
This Week's Hidden Gems: (BFAM)(CRHM)

Tracey Ryniec uncovers two top stocks that are flying under the radar.

CRHM : 6.18 (+3.87%)
BFAM : 76.62 (+0.33%)
CRH Medical Corporation Announces Acquisition in Florida and First Monitored Anesthesia Care Development Program in Washington State

CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it has completed an accretive transaction whereby CRH has acquired a 60% interest in a gastroenterology ("GI") anesthesia...

CRH.TO : 8.34 (+3.60%)
CRHM : 6.18 (+3.87%)
CRH Medical Corporation Announces Acquisition in Florida and First Monitored Anesthesia Care Development Program in Washington State

CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it has completed an accretive transaction whereby CRH has acquired a 60% interest in a gastroenterology ("GI") anesthesia...

CRH.TO : 8.34 (+3.60%)
CRHM : 6.18 (+3.87%)
CRH Medical Corporation Announces 2016 Fourth Quarter and Year-end Results

Annual revenue increases by 70% and adjusted operating EBITDA by 73%

CRH.TO : 8.34 (+3.60%)
CRHM : 6.18 (+3.87%)
CRH Medical Corporation Announces 2016 Fourth Quarter and Year-end Results

Annual revenue increases by 70% and adjusted operating EBITDA by 73%

CRH.TO : 8.34 (+3.60%)
CRHM : 6.18 (+3.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Business Summary

CRH Medical Corporation offers products and services to physicians for the treatment of gastrointestinal diseases primarily in the United States. The company provides the CRH O'Regan System, a single use, disposable and hemorrhoid banding technology for treating hemorrhoid grades I - IV. It distributes...

See More

Support & Resistance

2nd Resistance Point 6.39
1st Resistance Point 6.28
Last Price 6.18
1st Support Level 6.01
2nd Support Level 5.85

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.